These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

632 related items for PubMed ID: 17926251

  • 1. [Implementation of HPV vaccination in Germany].
    Schreckenberger C, Kaufmann AM, Schneider A.
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract] [Full Text] [Related]

  • 2. Screening: Testing times.
    Humphries C.
    Nature; 2012 Aug 30; 488(7413):S8-9. PubMed ID: 22932440
    [No Abstract] [Full Text] [Related]

  • 3. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P.
    Bull Mem Acad R Med Belg; 2007 Aug 30; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [Abstract] [Full Text] [Related]

  • 4. Who should get the HPV vaccine?
    Pichichero ME.
    J Fam Pract; 2007 Mar 30; 56(3):197-202. PubMed ID: 17343808
    [No Abstract] [Full Text] [Related]

  • 5. Human papillomavirus genotype distributions inform screening and vaccination policy.
    Pinkowish MD.
    CA Cancer J Clin; 2009 Mar 30; 59(5):280-1. PubMed ID: 19684300
    [No Abstract] [Full Text] [Related]

  • 6. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M.
    Cancer; 2007 Jun 25; 111(3):145-53. PubMed ID: 17487850
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, Louie KS, Quinn MA.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [Abstract] [Full Text] [Related]

  • 8. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.
    Med Klin (Munich); 2007 Jul 15; 102(7):515-23. PubMed ID: 17634869
    [Abstract] [Full Text] [Related]

  • 9. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE, Unger ER, Saraiya M.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):439-40. PubMed ID: 19318638
    [No Abstract] [Full Text] [Related]

  • 10. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V, Murtagh J.
    Issues Emerg Health Technol; 2007 Dec 01; (109):1-8. PubMed ID: 18062141
    [Abstract] [Full Text] [Related]

  • 11. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.
    Bull Acad Natl Med; 2007 Dec 01; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [Abstract] [Full Text] [Related]

  • 12. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R, Andrei C.
    Rev Med Chir Soc Med Nat Iasi; 2007 Dec 01; 111(1):144-54. PubMed ID: 17595860
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [Abstract] [Full Text] [Related]

  • 14. The impact of cytology screening and HPV vaccination on the burden of cervical cancer.
    Tay K, Tay SK.
    Asia Pac J Clin Oncol; 2011 Jun 19; 7(2):154-9. PubMed ID: 21585695
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R, Shin HR, Kim YT, Song YS, Sasagawa T, Inoue M, Park JS.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [Abstract] [Full Text] [Related]

  • 16. Screening for cervical cancer: controversy and contention or thoughtful analysis.
    Frable WJ.
    Cancer; 2007 Jun 25; 111(3):143-4. PubMed ID: 17487849
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].
    Gross G, Gissmann L, Hillemanns P, Ikenberg H, Kaufmann AM, Petry KU, Pfister H, Schneede P, Schneider A, Smola S, für das HPV-Management Forum.
    Dtsch Med Wochenschr; 2010 May 25; 135(21):1083-6. PubMed ID: 20486060
    [No Abstract] [Full Text] [Related]

  • 18. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
    Flaherty DK, Alkhateeb FM.
    Ann Pharmacother; 2009 Apr 25; 43(4):740-4. PubMed ID: 19276314
    [Abstract] [Full Text] [Related]

  • 19. [HPV vaccination and testing can improve cervix cancer screening].
    Bistoletti P, Andersson S, Johansson BC.
    Lakartidningen; 2009 Apr 25; 105(1-2):56-7. PubMed ID: 18293750
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of HPV 16, 18 vaccination in Brazil.
    Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'shea MK, Xavier Bosch F, de Sanjosé S, Franco EL.
    Vaccine; 2007 Aug 14; 25(33):6257-70. PubMed ID: 17606315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.